10th Aug 2011 16:00
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Simon Lowth, a Director of the Company, in AstraZeneca ordinary shares, has changed as detailed below.
On 9 August 2011, Mr Lowth exercised an option over 70,138 AstraZeneca ordinary shares at an option price of 1882 pence per share.
Following the exercise, Mr Lowth sold 61,713 of the 70,138 shares so acquired at a price of 2568 pence per share to cover the cost of exercise and associated taxes.
As a result of these transactions, Mr Lowth now has an interest in 261,363 AstraZeneca ordinary shares, which represents approximately 0.02% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
10 August 2011
Related Shares:
Astrazeneca